(Q73665661)

English

Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat

scientific article published on 01 April 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

author name string

L J Bristow

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D O'Connor

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Watts

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M S Duxon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P H Hutson

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1222-1236

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Novel and Selective 5-HT2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Activation of 5-HT 2B Receptors in the Medial Amygdala causes Anxiolysis in the Social Interaction Test in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Autoreceptor Antagonists Enhance the Effect of the Reuptake Inhibitor Citalopram on Extracellular 5-HT: this Effect Persists After Repeated Citalopram Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

W ay 100635-induced Augmentation of the 5-HT-elevating Action of Citalopram: Relative Importance of the Dose of the 5-HT 1A (Auto)receptor Blocker Versus that of the 5-HT Reuptake Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effect of 5-HT1A Receptor Antagonists on Citalopram-induced Increase in Extracellular Serotonin in the Frontal Cortex, Striatum and Dorsal Hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Anxiolytic-like effect of paroxetine in a rat social interaction test

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

How Long Should Pindolol Be Associated With Paroxetine to Improve the Antidepressant Response?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900191-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0028-3908(99)00191-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760364%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73665661&oldid=2162934918"